Completely agree. Oversold is a understatement now. Reversal is on the cards. But management has to come out and at least issue a letter to shareholders about status on safety study, progress on MM and other uses of cream. Also we haven't heard any new update on sublingual tablet.
News 
Market Data 
Discover 
AI
